Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Gains from Investment Securities (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Gains from Investment Securities readings, the most recent being $14808.0 for Q4 2021.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $14808.0 in Q4 2021 year-over-year; TTM through Sep 2021 was $1.8 million, a 16.47% decrease, with the full-year FY2025 number at -$45.4 million, changed N/A from a year prior.
  • Gains from Investment Securities hit $14808.0 in Q4 2021 for Minerva Neurosciences, down from $1.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $9.0 million in Q4 2019 to a low of $14808.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 3 years was $2.0 million (2020), compared with a mean of $2.6 million.
  • The widest YoY moves for Gains from Investment Securities: up 16.47% in 2021, down 77.07% in 2021.
  • Minerva Neurosciences' Gains from Investment Securities stood at $9.0 million in 2019, then crashed by 76.24% to $2.1 million in 2020, then plummeted by 99.31% to $14808.0 in 2021.
  • The last three reported values for Gains from Investment Securities were $14808.0 (Q4 2021), $1.8 million (Q3 2021), and $483391.0 (Q2 2021) per Business Quant data.